Aprogen Medicines Inc.

Informe acción KOSE:A007460

Capitalización de mercado: ₩304.9b

Aprogen Medicines Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Ki-Cheol Lim

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEOn/a
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

Recent updates

Aprogen Medicines Inc. (KRX:007460) May Have Run Too Fast Too Soon With Recent 25% Price Plummet

Sep 29
Aprogen Medicines Inc. (KRX:007460) May Have Run Too Fast Too Soon With Recent 25% Price Plummet

Is Aprogen Medicines (KRX:007460) Using Too Much Debt?

Aug 22
Is Aprogen Medicines (KRX:007460) Using Too Much Debt?

Aprogen Medicines Inc. (KRX:007460) Stock Rockets 41% As Investors Are Less Pessimistic Than Expected

Jul 21
Aprogen Medicines Inc. (KRX:007460) Stock Rockets 41% As Investors Are Less Pessimistic Than Expected

Aprogen Medicines Inc.'s (KRX:007460) 25% Share Price Plunge Could Signal Some Risk

May 31
Aprogen Medicines Inc.'s (KRX:007460) 25% Share Price Plunge Could Signal Some Risk

Is Aprogen Medicines (KRX:007460) A Risky Investment?

May 21
Is Aprogen Medicines (KRX:007460) A Risky Investment?

Aprogen Medicines Inc. (KRX:007460) Investors Are Less Pessimistic Than Expected

Feb 26
Aprogen Medicines Inc. (KRX:007460) Investors Are Less Pessimistic Than Expected

If You Had Bought Aprogen KIC's (KRX:007460) Shares Three Years Ago You Would Be Down 86%

Jan 07
If You Had Bought Aprogen KIC's (KRX:007460) Shares Three Years Ago You Would Be Down 86%

CEO

Ki-Cheol Lim (78 yo)

no data

Permanencia

Ki-Cheol Lim serves as the Chief Executive Officer of Aprogen Medicines Inc. (formerly known as Aprogen KIC Inc.) and serves as its Director and also served as Vice President. Ki-Cheol Lim also served at D...